Projects

Project area A focuses on the elucidation of innate and adaptive mechanisms related to the etiology, onset and course of chronic neuroinflammation.

While projects A1-A3 study principal processes of the immune response, projects A4-A6 mainly investigate the initiating (or perpetuating) adaptive immune factors in the disease, and A7-A9 focus on the balance of different adaptive immune responses. Important intracellular functions (A3) as well as antigen recognition (A4-A6) and differentiation or shaping of relevant pro-inflammatory or regulatory lymphocyte subpopulations (A7-A9) are in the center of these projects. Developing the human immune system, in particular the role of lymphocytes, in rodents (A9) will enable us to better achieve our goal of clinical translation.

To learn more about the individual projects, please visit the Project area A page.

Logo-SFB_Bilder-Projects-bilder_1

Project Area B addresses significant processes related to transmigration and infiltration of immune cells into the CNS as well as lesion development, lesion resolution and the impact for the overall functional outcome. These approaches often combine molecular and cellular mechanisms with innovative imaging tools, both in rodent experimental systems and in humans.

Projects B1-B3 investigate the routes of the immune cells and the involved processes at and beyond the blood brain barrier. From there project B4 goes on to the perivascular space and studies antigen-presenting cells (APC) and their capacity to shape the T cell response within the CNS. Project B5 and B6 study an inflammatory lesion and its impact on neuronal network and functional outcome. While project B5 examines this part of the pathology in patients with Multiple Sclerosis using a combination of imaging and advanced electrophysiology, project B6 investigates it in brain slices and rodent models. Projects B7 and B8 study processes of de- and remyelination, also analyzing underlying causes for demyelinated and remyelinated lesions in patients. Processes of neuronal injury as well as the regenerative capacity in the neuronal compartment are investigated in the projects B9 and B10.

To learn more about the individual projects, please visit the Project area B page.

Logo-SFB_Bilder-Projects-bilder_2

Project Area Z consists of a Clinical Translation Unit. The overall aim of this platform is to support various translational aspects of the CRC128. In particular, we pursue the following approaches:

  • Provide a platform for „proof-of-concept“ clinical studies (association with project A08)
  • Present a translational platform for support of single scientific projects in order to strengthen their translational aspects (examples are A01, A08, A09, B03, B07)
  • Provide a service platform in terms of infrastructure as well as biomaterial collection for use in individual scientific projects (examples are A08, A09, A10, B01, B08)

Schematic presentation of assays and methods provided within the CTU

To learn more about the individual projects, please visit the Project area Z page.

News

Tue, 08/09/2020
Study with identical twins shows that the early form of multiple sclerosis has a specific pattern
The tremendous heterogeneity of the human population presents a major obstacle in understanding how autoimmune diseases like multiple sclerosis (MS) contribute to variations in human peripheral immune signatures. To minimize heterogeneity, SFB researchers from Munich and Muenster made use of a unique cohort of 43 monozygotic twin pairs clinically discordant for MS and searched for […]...more
Mon, 09/03/2020
Breakthrough: SFB scientsists explain pathomechanism of Susac Syndrome
Münster. Neuroinflammation is often associated with blood-brain-barrier dysfunction, which contributes to neurological tissue damage. In a paper published in the renowned journal Nature Communications SFB 128 scientists from Mueenster reveal the pathophysiology of Susac syndrome (SuS), an enigmatic neuroinflammatory disease with central nervous system (CNS) endotheliopathy. By investigating immune cells from the blood, cerebrospinal fluid, […]...more
Wed, 04/03/2020
The brain is less immune-priviledged than we thought
Münster. Although the CNS is immune privileged, continuous search for pathogens and tumours by immune cells within the CNS is indispensable. Thus, distinct immune-cell populations also cross the blood–brain barrier independently of inflammation/under homeostatic conditions. It was previously shown that effector memory T cells populate healthy CNS parenchyma in humans and, independently, that CCR5-expressing lymphocytes […]...more